Abstract

Gynecologic cancers constitute a diverse group of malignancies affecting the female reproductive system, each presenting unique challenges in diagnosis and treatment. Molecular pathology has emerged as a pivotal field, unraveling the intricate molecular mechanisms underlying these cancers. This abstract provides a concise overview of the molecular pathology insights into cervical, uterine, ovarian, vulvar, and fallopian tube cancers, highlighting key biomarkers, genetic alterations, and potential therapeutic targets. Understanding the molecular landscape of gynecologic cancers is crucial for advancing personalized medicine, improving prognostic accuracy, and guiding targeted therapies